Orphan Drugs Market growing at a CAGR of 7.86%, to reach $166.40 billion by 2021

Global Orphan Drugs Market was worth $113.99 billion in 2016 and estimated to be growing at a CAGR of 7.86%, to reach $166.40 billion by 2021.

An orphan drug is a medicinal agent that has been created exclusively to treat an exceptional medical condition, the ailment itself being denoted to as an orphan disease.

View report: http://www.marketdataforecast.com/market-reports/global-orphan-drugs-market-1676/

An orphan disease affects a tiny percentage of the populace. Most of the rare illnesses are genetic, and thus are existent throughout the individual's entire life, even if the symptoms do not appear straightaway.

The growth of the Global Orphan Drugs Market is mainly driven by factors such as extended market exclusivity, rise in cognizance for prompt diagnosis, and improving healthcare infrastructure in developing countries. Moreover, government enticements in the form of endowments, tax credits, and fees waivers are the other major factors boosting the growth of the market. However, factors such as costly procedures & high initial investment, regulatory obstacles and clinical studies hurdles are hindering the growth of the market.

Download free sample report: http://www.marketdataforecast.com/market-reports/global-orphan-drugs-market-1676/request-sample

The Global Orphan Drugs market is segmented based on Type and Therapeutic. The market for Orphan Drugs, on the basis of Type is segmented into Biological and Non Biological. Non Biological Orphan Drugs lead the global market, on the basis of type with more than 60% of the market share. On the basis of Therapeutic, the global Orphan Drugs market is segmented into Haematology, Neurology, Oncology, and Others. On the basis of Therapeutics, Neurology accounts for almost 40% of the entire global market share.

The market has also been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. U.S accounted for the largest share in the global Orphan Drugs market in 2015, as it spends nearly 20% of its GDP on health. The global market outlook is projected to be positive as more and more governments are adopting policies to encourage this sector, especially in the developing countries.

Request discount report: http://www.marketdataforecast.com/market-reports/global-orphan-drugs-market-1676/request-discount

Presently, the market for orphan drugs represents only about 6% of the complete pharmaceutical market. An extremely conducive environment currently prevails for the growth of the orphan drugs market, thereby encouraging the entry of more companies into the market. The major companies dominating the global Orphan Drugs market are Novartis, GlaxoSmithKline, Roche, Alexion, Sanofi, Bristol Myers Squibb, Pfizer, Vertex, Celgene, and Merck.

Buy now: https://www.marketdataforecast.com/cart/buy-now/global-orphan-drugs-market-1676

Market Segmentation:
Type
• Introduction
• Biological
• Non Biological
• Y-o-Y Growth Analysis, By Type

Therapeutic
• Haematology
• Neurology
• Oncology
• Others

Scope of the report:
•Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

•Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail

•Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

•Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

•Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development

•A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

•Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

•An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

•Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Contact:
Abhishek Shukla
Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.